He didnt in 2nd part of theinterview, but stated that him and his entire team are excited about Leroblimab. They go on to say there are multiple drugs being tested, but they only highlight Leronlimab.

And lookie here... #1 on the list! Beating out Gilead!

https://www.biospace.com/article/clinical-cat...ril-13-17/